PRALUZATAMAB

Approval Year

Substance Class	Protein Created by `admin` on `Sat Dec 16 15:01:00 GMT 2023` Edited by `admin` on `Sat Dec 16 15:01:00 GMT 2023`
Protein Type	PROBODY
Protein Sub Type	IGG1
Sequence Origin	HUMANIZED MOUSE
Sequence Type	COMPLETE
Record UNII	X7F47LV4T7
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

PRALUZATAMAB

Official Name

English

ANTI-CD166 PROBODY-DRUG

Common Name

English

IMMUNOGLOBULIN G1, ANTI-(HUMAN ACTIVATED LEUKOCYTE CELL ADHESION MOLECULE) (HUMAN MONOCLONAL CX-191 .GAMMA.1-CHAIN), DISULFIDE WITH PRODOMAIN PROTEIN (SYNTHETIC MASKING MOIETY AND CLEAVABLE MOIETY PROTEASE SUBSTRATE-CONTAINING) FUSION PROTEIN WITH HUMAN

Common Name

English

PRALUZATAMAB [USAN]

Common Name

English

IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS CD166 (ACTIVATED LEUCOCYTE CELL ADHESION MOLECULE, ALCAM)), HUMANIZED MONOCLONAL ANTIBODY

Common Name

English

CX-191

Common Name

English

praluzatamab [INN]

Common Name

English

IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS CD166 ANTIGEN (ACTIVATED LEUKOCYTE CELL ADHESION MOLECULE)); HUMANIZED MONOCLONAL ANTIBODY; .GAMMA.1 HEAVY CHAIN HUMANIZED (1-450) (VH (HOMO SAPIENS IGHV2-5*01 (89%) (IGHD)-IGHJ4*01 (93%)) (10.7.13) (1-121)-HOM

Common Name

English

Code System Code Type Description

INN

10940